Legend Biotech (LEGN) Stock Rating Reiterated as Buy by H.C. Wainwright

H.C. Wainwright has reiterated its 'buy' rating for Legend Biotech (LEGN). The firm maintains a positive outlook on the company's future performance within the biotechnology sector. This endorsement could influence investor confidence and the trading behavior of Legend Biotech shares. For investors, a 'buy' rating may signal a potential upside in the stock price.